Cargando…
UCP2 silencing restrains leukemia cell proliferation through glutamine metabolic remodeling
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignancy derived from early T cell progenitors. Since relapsed T-ALL is associated with a poor prognosis improving initial treatment of patients is essential to avoid resistant selection of T-ALL. During initiation, developme...
Autores principales: | Sancerni, Tiphaine, Renoult, Ophélie, Luby, Angèle, Caradeuc, Cédric, Lenoir, Véronique, Croyal, Mikael, Ransy, Céline, Aguilar, Esther, Postic, Catherine, Bertho, Gildas, Dentin, Renaud, Prip-Buus, Carina, Pecqueur, Claire, Alves-Guerra, Marie-Clotilde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582289/ https://www.ncbi.nlm.nih.gov/pubmed/36275699 http://dx.doi.org/10.3389/fimmu.2022.960226 |
Ejemplares similares
-
UCP2 Deficiency Increases Colon Tumorigenesis by Promoting Lipid Synthesis and Depleting NADPH for Antioxidant Defenses
por: Aguilar, Esther, et al.
Publicado: (2019) -
UCP2 as a Cancer Target through Energy Metabolism and Oxidative Stress Control
por: Luby, Angèle, et al.
Publicado: (2022) -
UCP2 induces metabolic reprogramming to inhibit proliferation of cancer cells
por: Esteves, Pauline, et al.
Publicado: (2014) -
Glioblastoma Stem-Like Cells, Metabolic Strategy to Kill a Challenging Target
por: Garnier, Delphine, et al.
Publicado: (2019) -
The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity
por: Bricambert, Julien, et al.
Publicado: (2018)